PubMed Health⌕ Search

Biomedical subjects

I Samuel

Publications and source records attributed to I Samuel.

98 records · Page 6Linked to original sources
PubMedDate not supplied

Intrinsic fluorescence of some myxo- and paramyxoviruses and of their subviral fractions.

Fluorescence spectra of Sendai and influenza A(H1N1) viruses have different emission maxima; their quantum yield is much lower than that of tobacco mosaic virus. Solubilized envelopes and nucleoproteins of Sendai, influenza and mumps virus have different half-bandwidth and relative quantum yield values of emission, according to the agent used for disruption. Thus emission (as well as excitation and absorption) spectra of Triton X-100-solubilized envelopes show a marked hypsochromic shift as compared with the envelopes obtained by Tween20-disruption. The results are correlated with the different disruption extent achieved with the two agents.

Amino Acids↗
PubMedDate not supplied

The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated on chorioallantoic membrane fragments. Note 1. Kinetics of virus multiplication and of some biological characteristics in the presence and absence of ceruloplasmin.

The presence of ceruloplasmin in the inoculum inhibits the multiplication of influenza virus A/PR8/34 (H0N1) in chorioallantoic membrane fragments. Virus corpuscles that remain uncoupled to ceruloplasmin infect the host cells and their replication results in progens whose properties differ from those of controls inoculated in the absence of ceruloplasmin. The variation in time of the characteristics of the respective virus progens is discussed.

Allantois↗
PubMedDate not supplied

The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated in chorioallantoic membrane fragments. Note 2. Modifications occurring in the course of serial passages.

The results obtained at the first passage of ceruloplasmin-incubated influenza virus A/PR8/34 (H0N1) in chorioallantoic membrane fragments demonstrate the "trap effect" of ceruloplasmin and are characterized by the low values of the ratios between the hemagglutinating and neuraminidase activities and the infectivity of the resulted progens. At the 2nd passage, both in the absence and in the presence of ceruloplasmin the previously observed changes are accompanied by severe modifications in the antigenicity of the progens, as shown by the HAI titres obtained against a rabbit antiserum to influenza virus A/PR8/34 (H0N1).

Allantois↗
PubMedDate not supplied

Electron optic investigations on influenza virus A(H1N1) interacted with some aromatic compounds.

The morphological changes caused by the interaction of influenza virus A(H1N1) with three fluorescent aromatic compounds (a vinyl-sulfonic and an isocyano naphthalic acid derivative and the 4-acetylamino-naphthalene-1,8-dicarboxylic acid) were studied in the electron microscope. The intensity and type of the alterations depend on the chemical structure of the compounds and can be correlated with their effect on the biological activities of influenza virus.

Fluorescent Dyes↗
PubMedDate not supplied

A probable model of the inhibitory action of ceruloplasmin on the multiplication of some myxo- and paramyxoviruses.

A model of the interaction between virus glycoprotein and the glycoprotein moeity of ceruloplasmia was developed on the ground of previous experimental data referring to the inhibitory action of this enzyme on the multiplication of some influenza and parainfluenza viruses and on their hemagglutinin and neuraminidase activities. The model makes evident the "trap" action exerted by ceruloplasmin on virus particles, both in the early and in the later phases of virus multiplication.

Ceruloplasmin↗
PubMedDate not supplied

The effect of ceruloplasmin on experimental infection with influenza virus APR 8/34 (H0N1) in the mouse.

Ceruloplasmin administered in different variants confers on mice protection against experimental infection with influenza virus APR 8/34 (H0N1). The optimal variants are: inoculation of an extemporaneous virus-ceruloplasmin mixture, followed by two additional ceruloplasmin applications (which confers maximum protection against initial infection) and the administration of ceruloplasmin prior to virus inoculation (which assures the highest resistance to challenge infection).

Animals↗